U.S. markets close in 1 hour 15 minutes
  • S&P 500

    4,283.20
    -114.74 (-2.61%)
     
  • Dow 30

    33,481.92
    -783.45 (-2.29%)
     
  • Nasdaq

    13,405.50
    -363.42 (-2.64%)
     
  • Russell 2000

    1,987.99
    +0.07 (+0.00%)
     
  • Crude Oil

    83.01
    -2.13 (-2.50%)
     
  • Gold

    1,840.70
    +8.90 (+0.49%)
     
  • Silver

    23.85
    -0.47 (-1.93%)
     
  • EUR/USD

    1.1328
    -0.0027 (-0.24%)
     
  • 10-Yr Bond

    1.7260
    -0.0210 (-1.20%)
     
  • GBP/USD

    1.3479
    -0.0067 (-0.49%)
     
  • USD/JPY

    113.6930
    +0.0380 (+0.03%)
     
  • BTC-USD

    35,841.60
    +1,041.54 (+2.99%)
     
  • CMC Crypto 200

    813.48
    +2.88 (+0.36%)
     
  • FTSE 100

    7,297.15
    -196.98 (-2.63%)
     
  • Nikkei 225

    27,588.37
    +66.11 (+0.24%)
     

At US$45.77, Is It Time To Put Avanos Medical, Inc. (NYSE:AVNS) On Your Watch List?

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • AVNS

Avanos Medical, Inc. (NYSE:AVNS), is not the largest company out there, but it led the NYSE gainers with a relatively large price hike in the past couple of weeks. As a mid-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. But what if there is still an opportunity to buy? Let’s take a look at Avanos Medical’s outlook and value based on the most recent financial data to see if the opportunity still exists.

Check out our latest analysis for Avanos Medical

Is Avanos Medical still cheap?

According to my valuation model, Avanos Medical seems to be fairly priced at around 5.5% below my intrinsic value, which means if you buy Avanos Medical today, you’d be paying a fair price for it. And if you believe the company’s true value is $48.44, then there isn’t much room for the share price grow beyond what it’s currently trading. So, is there another chance to buy low in the future? Given that Avanos Medical’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us an opportunity to buy later on. This is based on its high beta, which is a good indicator for share price volatility.

What kind of growth will Avanos Medical generate?

earnings-and-revenue-growth
earnings-and-revenue-growth

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. Avanos Medical's earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.

What this means for you:

Are you a shareholder? It seems like the market has already priced in AVNS’s positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value?

Are you a potential investor? If you’ve been keeping an eye on AVNS, now may not be the most optimal time to buy, given it is trading around its fair value. However, the optimistic prospect is encouraging for the company, which means it’s worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

If you want to dive deeper into Avanos Medical, you'd also look into what risks it is currently facing. For example - Avanos Medical has 1 warning sign we think you should be aware of.

If you are no longer interested in Avanos Medical, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.